Evaluation of the effectiveness of remdesivir in severe COVID-19 using observational data from a prospective national cohort study
View ORCID ProfileB N Arch, View ORCID ProfileD Kovacs, View ORCID ProfileJ T Scott, View ORCID ProfileA P Jones, View ORCID ProfileE M Harrison, View ORCID ProfileA Rosala-Hallas, View ORCID ProfileC G Gamble, View ORCID ProfileP J M Openshaw, View ORCID ProfileJ K Baillie, View ORCID ProfileM G Semple ISARIC4C Investigators
doi: https://doi.org/10.1101/2021.06.18.21259072
B N Arch
1Liverpool Clinical Trials Centre, Clinical Directorate, Faculty of Health and Life Sciences, University of Liverpool, UK
D Kovacs
2Institute of Biodiversity, Animal health and Comparative Medicine, University of Glasgow, Glasgow, UK
J T Scott
3MRC-University of Glasgow Centre for Virus Research, Glasgow, UK
A P Jones
1Liverpool Clinical Trials Centre, Clinical Directorate, Faculty of Health and Life Sciences, University of Liverpool, UK
E M Harrison
4Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, UK
A Rosala-Hallas
1Liverpool Clinical Trials Centre, Clinical Directorate, Faculty of Health and Life Sciences, University of Liverpool, UK
C G Gamble
1Liverpool Clinical Trials Centre, Clinical Directorate, Faculty of Health and Life Sciences, University of Liverpool, UK
P J M Openshaw
5National Heart and Lung Institute, Imperial College London, London, UK
J K Baillie
6Roslin Institute, University of Edinburgh, Edinburgh, UK
M G Semple
7Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK
8Department of Respiratory Medicine, Alder Hey Children’s Hospital, Liverpool, UK
Data Availability
This work uses data provided by patients and collected by the NHS as part of their care and support #DataSavesLives. ISARIC4C welcomes applications for data and material access through our Independent Data and Material Access Committee (https://isaric4c.net).
Posted March 09, 2022.
Evaluation of the effectiveness of remdesivir in severe COVID-19 using observational data from a prospective national cohort study
B N Arch, D Kovacs, J T Scott, A P Jones, E M Harrison, A Rosala-Hallas, C G Gamble, P J M Openshaw, J K Baillie, M G Semple
medRxiv 2021.06.18.21259072; doi: https://doi.org/10.1101/2021.06.18.21259072
Evaluation of the effectiveness of remdesivir in severe COVID-19 using observational data from a prospective national cohort study
B N Arch, D Kovacs, J T Scott, A P Jones, E M Harrison, A Rosala-Hallas, C G Gamble, P J M Openshaw, J K Baillie, M G Semple
medRxiv 2021.06.18.21259072; doi: https://doi.org/10.1101/2021.06.18.21259072
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2887)
- Dermatology (247)
- Emergency Medicine (433)
- Epidemiology (12631)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4493)
- Geriatric Medicine (411)
- Health Economics (718)
- Health Informatics (2874)
- Health Policy (1059)
- Hematology (381)
- HIV/AIDS (912)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4263)
- Nursing (228)
- Nutrition (626)
- Oncology (2232)
- Ophthalmology (637)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6843)
- Radiology and Imaging (1505)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (378)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)